Knut Erling Juul-Hansen
Papers
1
Total Citations
2
H-Index
1
About
Knut Erling Juul-Hansen is a researcher whose work sits at the intersection of gynecologic oncology and health economics, with a particular focus on improving surgical outcomes for endometrial carcinoma. His most cited study, a 2024 cost-effectiveness analysis, compares sentinel lymph node biopsy (SLN) to traditional lymphadenectomy in intermediate- and high-risk endometrial cancer patients. This work provides crucial evidence that SLN—a less invasive staging technique—can be both clinically effective and economically viable, potentially reducing morbidity and healthcare costs without compromising oncologic safety. By quantifying the trade-offs between these surgical approaches, Juul-Hansen’s research directly informs clinical guidelines and resource allocation in cancer care. Though his citation count is still growing, his contribution is timely and impactful, addressing a key debate in modern gynecologic oncology. His work exemplifies how rigorous health economics can shape surgical practice, making him a valuable voice for evidence-based, patient-centered cancer treatment.
Research Focus
Key Achievements
Top Papers
- 1